Last year, Femtech, a healthcare category focused on issues that affect women differently and/or disproportionately, received nearly $800 million in funding – and it’s estimated… Read More »Cancer Detecting Bras & Other Trends And Opportunities In Femtech
Women Focused Medical Stock
Two small biotech companies focused on underserved medical needs and patient populations – including neuropsychiatric/neurological disorders and women’s health issues – are among five Buy-rated… Read More »Big Upside Potential At Low Prices For Aggressive Traders
This biotech company’s drug for treating hypoactive sexual desire disorder in women is expected to receive FDA approval in early January 2019. With increasing market… Read More »The New – And More Effective – Female Viagra: An Attractive Opportunity?